CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $8.71B, above the global median of $1.14B
- FinancialsAltman Z-Score 8.85: safe zone
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.23%
Annual Rate
INR 2.00Paid annual
Payout Ratio
13.4%Sustainable
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
828.77BINR8.71B · vs all stocks (USD)
Trailing P/E
56.72xvs Medical Care Facilities peers
Revenue (TTM)
87.12BINR915.29M · vs all stocks (USD)
Profit Margin
16.72%vs Medical Care Facilities peers
Beta
0.0990xvs all stocks
52-Week Change
-27.75%vs all stocks
Market Capitalization
828.77BINR8.71B · vs all stocks (USD)
Enterprise Value
840.78BINR8.83B · vs all stocks (USD)
Trailing P/E
56.72xvs Medical Care Facilities peers
Forward P/E
36.21xvs Medical Care Facilities peers
PEG Ratio
11.99xvs Medical Care Facilities peers
Price to Sales (TTM)
9.45xvs Medical Care Facilities peers
Price to Book (MRQ)
7.66xvs Medical Care Facilities peers
Enterprise to Revenue
9.65xvs Medical Care Facilities peers
Enterprise to EBITDA
37.44xvs Medical Care Facilities peers
Gross Margin
78.30%vs Medical Care Facilities peers
Profit Margin
16.72%vs Medical Care Facilities peers
Operating Margin
19.73%vs Medical Care Facilities peers
Return on Assets (TTM)
8.37%vs Medical Care Facilities peers
Return on Equity (TTM)
13.42%vs Medical Care Facilities peers
Revenue (TTM)
87.12BINR915.29M · vs all stocks (USD)
Revenue per Share (TTM)
89.59INRUpdated Oct 29, 2026Quarterly Revenue Growth
16.70%vs Medical Care Facilities peers
Gross Profit (TTM)
54.47BINR572.23M · vs all stocks (USD)
EBITDA (TTM)
24.85BINR261.07M · vs all stocks (USD)
Net Income (TTM)
14.57BINR153.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.70%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
16.33BINR171.60M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
14.42BINR151.54M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.00INRUpdated Oct 29, 2026Trailing Annual Dividend Yield
0.23%vs all stocks
Payout Ratio
13.41%vs Medical Care Facilities peers
Revenue
82.25BINRFY2026 · Mar 31, 2026Cost of Goods Sold
17.90BINRFY2026 · Mar 31, 2026Gross Profit
64.36BINRFY2026 · Mar 31, 2026Operating Income
18.77BINR197.23M · vs all stocks (USD)
Pre-tax Income
16.76BINRFY2026 · Mar 31, 2026Income Tax Expense
2.33BINRFY2026 · Mar 31, 2026Net Income
14.42BINRFY2026 · Mar 31, 2026EBIT
18.91BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
24.26BINRFY2026 · Mar 31, 2026Selling, General & Administrative
21.96BINRFY2026 · Mar 31, 2026Other Operating Expenses
6.65BINRFY2026 · Mar 31, 2026Non-operating Interest Income
1.15BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
2.15BINRFY2026 · Mar 31, 2026EPS (Basic)
14.83INRFY2026 · Mar 31, 2026EPS (Diluted)
14.76INRFY2026 · Mar 31, 2026Basic Shares Outstanding
972.46MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
972.46MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
14.39BINRFY2026 · Mar 31, 2026Free Cash Flow
-295.80MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
6.66BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
16.76BINRFY2026 · Mar 31, 2026Stock-based Compensation
483.30MINRFY2026 · Mar 31, 2026Other Non-cash Items
795.10MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-3.23BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-414.00MINRFY2026 · Mar 31, 2026Capital Expenditures
-14.68BINRFY2026 · Mar 31, 2026Net Acquisitions
406.60MINRFY2026 · Mar 31, 2026Purchase of Investments
-38.50MINRFY2026 · Mar 31, 2026Sale of Investments
12.80MINRFY2026 · Mar 31, 2026Other Investing Activity
-143.50MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-14.45BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
5.39BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-1.44BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
284.50MINRFY2026 · Mar 31, 2026Common Dividends Paid
-1.46BINRFY2026 · Mar 31, 2026Net Financing Cash Flow
3.12BINRFY2026 · Mar 31, 2026Shares Outstanding
973.31MSharesUpdated Oct 29, 2026Float Shares
699.04MSharesUpdated Oct 29, 2026% Held by Insiders
28.20%vs all stocks
% Held by Institutions
59.77%vs all stocks
Total Cash (MRQ)
6.66BINR69.95M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.84INRUpdated Oct 29, 2026Total Debt (MRQ)
34.78BINR365.44M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3237xvs Medical Care Facilities peers
Current Ratio (MRQ)
0.8893xvs Medical Care Facilities peers
Book Value per Share (MRQ)
110.43INRUpdated Oct 29, 2026Total Assets
172.31BINR1.81B · vs all stocks (USD)
Total Current Assets
19.45BINRFY2026 · Mar 31, 2026Total Liabilities
64.84BINRFY2026 · Mar 31, 2026Total Non-current Assets
152.86BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
42.97BINRFY2026 · Mar 31, 2026Total Current Liabilities
21.87BINRFY2026 · Mar 31, 2026Cash
917.30MINRFY2026 · Mar 31, 2026Cash Equivalents
5.74BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
6.66BINRFY2026 · Mar 31, 2026Other Short-term Investments
26.30MINRFY2026 · Mar 31, 2026Accounts Receivable
9.70BINRFY2026 · Mar 31, 2026Inventory
1.14BINRFY2026 · Mar 31, 2026Accounts Payable
8.59BINRFY2026 · Mar 31, 2026Short-term Debt
5.00BINRFY2026 · Mar 31, 2026Other Current Liabilities
18.00MINRFY2026 · Mar 31, 2026Long-term Debt
29.78BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
2.68BINRFY2026 · Mar 31, 2026Common Stock (Book)
9.73BINRFY2026 · Mar 31, 2026Retained Earnings
43.96BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
107.47BINR1.13B · vs all stocks (USD)
52-Week Low
797.00INRUpdated Oct 29, 202652-Week High
1.19KINRUpdated Oct 29, 202652-Week Change
-27.75%vs all stocks
Beta
0.0990xvs all stocks
50-Day MA
965.22INRUpdated Oct 29, 2026200-Day MA
1.02KINRUpdated Oct 29, 2026Avg 10-Day Volume
2.88MSharesUpdated Oct 29, 2026Avg 30-Day Volume
2.86MSharesUpdated Oct 29, 2026Diluted EPS (TTM)
14.91INRUpdated Oct 29, 20267 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.17Receivables vs revenue divergence: 2.13
Financial Health
Altman Z-Score 8.85: safe zoneNotable
Altman Z-Score: 8.85
High earnings qualityNotable
Earnings Quality Score: 0.72
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $8.71B, above the global median of $1.14BNotable
Market cap (USD): 8,707,096,268.695Global Median: 1,138,450,684.034
Revenue is $915.29M, above the global median of $562.3MNotable
Revenue (USD): 915,288,002.249Global Median: 562,304,852.367
Levered free cash flow is $151.54M, above the global median of $18.69MNotable
Levered free cash flow (USD): 151,539,594.6Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Weir Group plc
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Delton Technology Guangzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
PBF Energy Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Empresas Copec S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hengyi Petrochemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Advanced Energy Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sangfor Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Nanya New Material Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Iteq Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
JSW Energy Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Afya Ltd.
5 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value
Hygon Information Technology Co. Ltd.
5 interpretationsRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Fortis Healthcare Ltd.
5 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetReceivables Heavy and GrowingMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity